SCHEMBL13622613

SCHEMBL13622613

CCOC(=O)/C(=C/C=C/N(c1ccccc1)c1ccccc1)S(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.49
▸ LMNA P02545 4/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ MEN1 O00255 4/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ MAPT P10636 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ TP53 P04637 1/20 0.41
▸ GAA P10253 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ POLB P06746 2/20 0.39
▸ APP P05067 1/20 0.39
▸ TAS2R14 Q9NYV8 1/20 0.37
▸ NOD2 Q9HC29 1/20 0.37
▸ NOD1 Q9Y239 1/20 0.37
▸ GLA P06280 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14261080 0.88 ALDH1A1 (0.38) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL12864658 0.80 ALDH1A1 (0.46) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL18415027 0.80 ALDH1A1 (0.46) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL24297096 0.80 LMNA (0.40) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL13609924 0.79 ALDH1A1 (0.45) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL14456207 0.79 ALDH1A1 (0.45) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL4547548 0.79 ALDH1A1 (0.45) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL24293675 0.79 ALDH1A1 (0.41) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL21128717 0.76 ALDH1A1 (0.43) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL17567383 0.76 ALDH1A1 (0.40) ALDH1A1LMNASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190285773-A1 LENS FOR SPECTACLES, SPECTACLES, PROTECTIVE SHEET, AND DISPLAY FUJIFILM CORPORATION (JP) 2019-09-19 — — US disclosed
US-7622603-B2 Transesterifying a delta-aminopentadienoic acid ester that is alpha-substituted with an electron-withdrawing group (e.g., phenylsulfonyl) by reaction with an alcohol; tetraalkyl titanate catalyst FUJIFILM CORPORATION (JP) 2009-11-24 — — US disclosed
US-20080076940-A1 PROCESS FOR PRODUCING S-AMINOPENTADIENOATE COMPOUND FUJIFILM CORPORATION (JP) 2008-03-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076940-A1 PROCESS FOR PRODUCING S-AMINOPENTADIENOATE COMPOUND AASDHPPT, ADH1A, SSR4 ALDH1A1 422/4885LMNA 4035/4885SMN1; SMN2 3669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback